BioSpace News Archive

Business

Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results

The Company reported a net loss of $7.6 million, or $0.22 per share, compared to a net loss of $4.2 million, or $0.30 per share, in the third quarter ended September 30, 2016.

November 7, 2017

·

10 min read

BioForest

LumiThera Unveils LIGHTSITE I Dry AMD Clinical Interim Data

The 30-subject pilot study funded from a SBIR grant awarded to the Company from the NIH and the National Eye Institute is testing each subject’s vision and examining disease pathology in the eye, following PBM treatments for up to one year.

November 7, 2017

·

2 min read

Business

University Hospital Bonn Launches New Technology to Help Geneticists Worldwide Find the Genetic Cause of Rare Syndromes

Through a partnership with Boston-based FDNA, clinicians worldwide can now instantly upload qualifying, de-identified case information to IGSB for a full assessment, including facial analysis and genetic testing.

November 7, 2017

·

3 min read

Genetown

Augmenix Announces Medicare Reimbursement Rates for the New CPT Code 55874, Which Will be Used to Bill SpaceOAR Hydrogel, Effective January 2018

The code, which goes into effect January 1, 2018, will enable both hospitals and physicians to receive payment.

November 7, 2017

·

6 min read

Drug Development

Novan Announces Plan to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution

Under the proposed transaction, a new entity established by the third party would provide both the necessary capital to fund and the clinical expertise to execute an additional Phase 3 pivotal trial for SB204.

November 7, 2017

·

4 min read

Business

Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update December 2019

These results are included in the Company’s Quarterly Report on Form 10-Q, which has been filed with the U.S. SEC and is available at www.sec.gov.

November 7, 2017

·

6 min read

BioMidwest

Huber Personalized Medicine Brings GAINSWave to Cincinnati

This breakthrough noninvasive medical procedure uses a form of shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction symptoms.

November 7, 2017

·

2 min read

Business

AlloSource Announces Bob Lay as COO

With over 20 years of experience in both finance and operations, Bob has a broad-based understanding of how each department within an organization impacts another.

November 7, 2017

·

2 min read

Drug Development

GSK Presents New Data at ACR for BENLYSTA (belimumab) for Subcutaneous Use (SC), Showing Reduced Need to Increase Corticosteroid Dose

The data being presented at the 2017 ACR/AHRP) show that weekly treatment with BENLYSTA SC 200mg reduced the need to increase the dose of corticosteroid (one standard of care medication for patients with SLE).

November 7, 2017

·

11 min read

Business

Celldex Reports Third Quarter 2017 Results

Cash, cash equivalents and marketable securities as of September 30, 2017 were $140.5 million compared to $154.0 million as of June 30, 2017.

November 7, 2017

·

17 min read